See all
 | Articles: Clinical Pharmacology |
Prospective evaluation of weekly topotecan in recurrent platinum-resistant epithelial ovarian cancer
International Journal of Gynecological Cancer, 05/16/08
Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report
Archives of Gynecology and Obstetrics, 05/16/08


A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes
American Journal of Obstetrics and Gynecology, 05/15/08
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
Breast Cancer Research and Treatment, 05/15/08
A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women
Breast Cancer Research and Treatment, 05/15/08
Impact of gonadotrophin stimulation for assisted reproductive technology on ovarian ageing and menopause
Reproductive BioMedicine Online, 05/14/08
Prospective comparison of short and long GnRH agonist protocols using recombinant gonadotrophins for IVF/ICSI treatments
Reproductive BioMedicine Online, 05/14/08
Cost–effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
Breast Cancer Research and Treatment, 05/14/08
Depot-medroxyprogesterone acetate: an update
Archives of Gynecology and Obstetrics, 05/13/08
Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes
Journal of Assisted Reproduction and Genetics, 05/13/08
|
Receive daily email updates on Clinical Pharmacology
|
|
Indexed Journals: Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology
more...
|
250 Available Pages
 |
|
|
| Sponsor |
|
 |
| Read a Different Specialty |
 |
|
|
|
 |
| Profession Index |
 |
|
|
|
 |
|
|
|
| Sponsor |
|